(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.The reported patient effects of hypersensitivity is a known observed and potential patient effects as listed in the omnilink elite electronic instructions for use.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.
|
It was reported by the patient that she had a 6.0/39 mm omnilink elite stent deployed in her subclavian artery on (b)(6) 2013.Beginning (b)(6) 2016, she is experiencing excessive itching.The patient was previously determined to have a nickel allergy.She has not gone back to her physician yet, but plans on making an appointment for diagnosis.No treatment has been performed at this time.No additional information was provided.
|